Skip to main content

Table 6 Serum FST levels in patients with LADC according to T category

From: Association of serum follistatin levels with histological types and progression of tumor in human lung cancer

 

n

Mean ± SD, pg/mL

Minimum–maximum, pg/mL

Healthy subjects

37

760.09 ± 115.65

570.88–1170.24

Benign diseases

22

1225.60 ± 323.40#

608.36–1763.76

LADC

33

  

 T1

11

1492.72 ± 378.65#*

877.29–2241.09

 T2

17

1474.96 ± 237.98#*

1150.05–1900.14

 T3

2

1797.86 ± 170.47

1627.38–1968.33

 T4

3

1763.76 ± 192.87

1491.00–1900.14

  1. #P < 0.01 compared with the healthy group; * P < 0.05, ** P < 0.01, compared with benign disease group